Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00030498

Locations


United States, Ohio
	Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
	Columbus, Ohio, United States, 43210-1240

Sponsors and Collaborators

Cancer and Leukemia Group B

National Cancer Institute (NCI)

Investigators


Study Chair:	Antonius A. Miller, MD	Wake Forest University